14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Tue, 7 May 2024

Trading levels for NBIX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 144.96 2.29 %
R2 143.80 1.48 %
R1 143.09 0.98 %
Current price: 141.71
Support S1 140.79 -0.649 %
S2 140.08 -1.15 %
S3 138.93 -1.96 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 143.74 1.43 %
R2 143.03 0.93 %
R1 141.80 0.0635 %
Current price 141.71
Support S1 140.09 -1.14%
S2 136.29 -3.82%
S3 133.84 -5.55%

NBIX Predictions History

1 year ago
JS predicted that NBIX for 2022-12-22 is going $119.80 (-2.12%)

1 year ago
PredictionBot.Kathy predicted that NBIX for 2022-12-22 is going $118.68 (-3.04%)

1 year ago
PredictionBot.Warren predicted that NBIX for 2022-12-22 is going $119.23 (-2.59%)

2 years ago
JS predicted that NBIX for 2022-01-05 is going

2 years ago
JS predicted that NBIX for 2022-01-05 is going $87.33 (4.90%)

2 years ago
JS predicted that NBIX for 2021-06-21 is going $101.10 (-0.68%)

2 years ago
catolino.aurelie.244443 predicted that NBIX for 2021-06-21 is going

Rank:

3 years ago
JS predicted that NBIX for 2020-05-26 is going $122.95 (-1.48%)

3 years ago
2poJeff predicted that NBIX for 2020-05-26 is going $120.55 (-3.41%)

4 years ago
joe1234 predicted that NBIX for 2019-05-13 is going $76.60 (0.49%)

Click to get the best stock tips daily for free!

About Neurocrine Biosciences

Neurocrine Biosciences Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, a VMAT2 inhibitor for the treatment of tardive dyskinesia. The company's commercial products include ON... NBIX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT